跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 86,817 条关于
“biparatopic antibody therapy”
全部
86,817
临床试验
58,575
药物
6,653
机构
165
资讯
21,424
去年
FDA Approves First Anti-TFPI Antibody and Biparatopic Antibody Therapy
4个月前
Lotte Biologics Expands Manufacturing Partnership with Ottimo Pharma for Biparatopic Antibody Development
2个月前
Attovia Therapeutics Raises $289M in Upsized IPO to Advance Biparatopic Nanobody Pipeline in Immunology
5个月前
Phrontline Biopharma's TJ106 Shows Promise Against HER2-Low and ADC-Resistant Tumors in Preclinical Studies
5年前
FDA Revokes Emergency Use Authorization for Bamlanivimab Monotherapy Against COVID-19
去年
Jazz Pharmaceuticals Acquires Global Rights to Zanidatamab in $1.76 Billion Deal with Zymeworks
11个月前
Salubris Biotherapeutics Reports Promising Phase 1 Results for 5T4-Targeted ADC JK06 in Advanced Solid Tumors
去年
Phase 3 Trial of Clazakizumab Fails to Meet Primary Endpoint in Chronic Active Antibody-Mediated Kidney Transplant Rejection
去年
SparX Biopharmaceutical and Mitsubishi Tanabe Pharma America Partner on Novel Immune Cell-Targeting ADC Program
去年
Alphamab Oncology's HER2-Targeting ADC JSKN003 Receives FDA Orphan Drug Designation for Gastric Cancer
第 1 页，共 2143 页
上一页
下一页
